Page 2 - Tami Tillotson Martin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tami tillotson martin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tami Tillotson Martin Today - Breaking & Trending Today

Retirement Planning Co of New England Inc. Lowers Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Retirement Planning Co of New England Inc. reduced its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 8.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,952 shares of the specialty pharmaceutical company’s stock after selling 2,625 shares during the […] ....

United States , Tami Tillotson Martin , Frank Mottola , Piper Sandler , Supernus Pharmaceuticals Price Performance , Securities Exchange Commission , England Inc , Supernus Pharmaceuticals Inc , News Ratings For Supernus Pharmaceuticals Daily , Retirement Planning Co , Northern Trust Corp , Guggenheim Capital , Commonwealth Equity Services , Quarter For Supernus Pharmaceuticals , Exchange Commission , Supernus Pharmaceuticals , Geode Capital Management , New England , Free Report , Capital Management , Trust Corp , Equity Services , Tillotson Martin , Get Free Report , Visit Holdingschannel , Supernus Pharmaceuticals Daily ,

StockNews.com Lowers Supernus Pharmaceuticals (NASDAQ:SUPN) to Hold

StockNews.com lowered shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday. Separately, Piper Sandler lifted their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on […] ....

United States , Frederickm Hudson , Piper Sandler , Tami Tillotson Martin , Tower Research Capital , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals Price Performance , News Ratings For Supernus Pharmaceuticals Daily , Cerity Partners , China Universal Asset Management Co , Securities Exchange Commission , Supernus Pharmaceuticals , Free Report , Get Free Report , Tillotson Martin , Exchange Commission , Director Frederick , Jacobson Investment Advisors , Employees Retirement System , Research Capital , China Universal Asset Management , Universal Asset Management , Supernus Pharmaceuticals Daily , Nasdaq Supn , Stocknews Com ,

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Lowered to Hold at StockNews.com

StockNews.com downgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a hold rating in a research note released on Friday morning. Separately, Piper Sandler lowered their target price on Supernus Pharmaceuticals from $43.00 to $42.00 and set an overweight rating on the stock in a research note on Wednesday, October […] ....

United States , Piper Sandler , Tami Tillotson Martin , Supernus Pharmaceuticals Trading , Tower Research Capital , Supernus Pharmaceuticals , Institutional Investors Weigh In On Supernus Pharmaceuticals , Insider Activity At Supernus Pharmaceuticals , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals Company Profile , Mendota Financial Group , News Ratings For Supernus Pharmaceuticals Daily , Free Report , Get Free Report , Tillotson Martin , Jacobson Investment Advisors , Employees Retirement System , Financial Group , Research Capital , Supernus Pharmaceuticals Daily , Nasdaq Supn , Stocknews Com ,

Supernus Pharmaceuticals (NASDAQ:SUPN) Price Target Cut to $42.00

Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) had its price objective decreased by Piper Sandler from $43.00 to $42.00 in a research note issued to investors on Wednesday, Benzinga reports. Piper Sandler currently has an overweight rating on the specialty pharmaceutical company’s stock. Separately, StockNews.com raised shares of Supernus Pharmaceuticals from a hold rating to a […] ....

United States , Piper Sandler , Tami Tillotson Martin , Securities Exchange Commission , Hedge Funds Weigh In On Supernus Pharmaceuticals , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Supernus Pharmaceuticals Price Performance , Mendota Financial Group , News Ratings For Supernus Pharmaceuticals Daily , Tower Research Capital , Free Report , Get Free Report , Tillotson Martin , Exchange Commission , Jacobson Investment Advisors , Employees Retirement System , Financial Group , Research Capital , Supernus Pharmaceuticals Daily , Nasdaq Supn , Lower Price Target ,

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Lowered to Hold at StockNews.com

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Lowered to Hold at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Tami Tillotson Martin , Supernus Pharmaceuticals Trading , Metlife Investment Management , Securities Exchange Commission , News Ratings For Supernus Pharmaceuticals Daily , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Institutional Trading Of Supernus Pharmaceuticals , Sei Investments Co , Get Free Report , Tillotson Martin , Exchange Commission , Montreal Can , Life Investment Management , Sei Investments , Supernus Pharmaceuticals Daily ,